Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J van Diest

Showing results (11-20 of 305) with videos related to

Pageof 31
Sort By:
Human Pathology|April 1, 1991
The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patientsP J van Diest, J P Baak
The American Journal of Surgical Pathology|July 21, 1998
Borderline ovarian tumorsJ P Baak, P J van Diest
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Epigenetics in ovarian cancerL M S Seeber, P J van Diest
Lancet (London, England)|December 6, 2001
Sentinel-node biopsy in breast cancerH Torrenga, P J van Diest, S Meijer
Journal of Clinical Pathology|June 29, 2001
The Journal of Clinical Pathology online (http://www.jclinpath.com): free for the developing countriesP J Van Diest, A Williamson, H Holzel
Current Molecular Medicine|April 22, 2011
Mammary development and breast cancer: the role of stem cellsC Ercan, P J van Diest, M Vooijs
Journal of Clinical Pathology|February 19, 1999
Proliferation markers in tumours: interpretation and clinical valueP J van Diest, G Brugal, J P Baak
Annals of Surgery|April 5, 2000
Re: Chu et al "Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?"F D Rahusen, S Meijer, P J van Diest
Journal of Clinical Pathology|November 1, 1996
Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometryE Bergers, P J van Diest, J P Baak
Analytical and Quantitative Cytology and Histology|October 1, 1996
Reproducibility of subjective immunoscoring of steroid receptors in breast cancerP J van Diest, D R Weger, J Lindholm
Pageof 31

Showing results (11-20 of 305) with videos related to

Sort By:
Pageof 31
Human Pathology|April 1, 1991
The morphometric prognostic index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patientsP J van Diest, J P Baak
The American Journal of Surgical Pathology|July 21, 1998
Borderline ovarian tumorsJ P Baak, P J van Diest
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2012
Epigenetics in ovarian cancerL M S Seeber, P J van Diest
Lancet (London, England)|December 6, 2001
Sentinel-node biopsy in breast cancerH Torrenga, P J van Diest, S Meijer
Journal of Clinical Pathology|June 29, 2001
The Journal of Clinical Pathology online (http://www.jclinpath.com): free for the developing countriesP J Van Diest, A Williamson, H Holzel
Current Molecular Medicine|April 22, 2011
Mammary development and breast cancer: the role of stem cellsC Ercan, P J van Diest, M Vooijs
Journal of Clinical Pathology|February 19, 1999
Proliferation markers in tumours: interpretation and clinical valueP J van Diest, G Brugal, J P Baak
Annals of Surgery|April 5, 2000
Re: Chu et al "Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?"F D Rahusen, S Meijer, P J van Diest
Journal of Clinical Pathology|November 1, 1996
Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometryE Bergers, P J van Diest, J P Baak
Analytical and Quantitative Cytology and Histology|October 1, 1996
Reproducibility of subjective immunoscoring of steroid receptors in breast cancerP J van Diest, D R Weger, J Lindholm
Pageof 31